These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29944958)

  • 41. Two-site recognition of Staphylococcus aureus peptidoglycan by lysostaphin SH3b.
    Gonzalez-Delgado LS; Walters-Morgan H; Salamaga B; Robertson AJ; Hounslow AM; Jagielska E; Sabała I; Williamson MP; Lovering AL; Mesnage S
    Nat Chem Biol; 2020 Jan; 16(1):24-30. PubMed ID: 31686030
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Direct observation of Staphylococcus aureus cell wall digestion by lysostaphin.
    Francius G; Domenech O; Mingeot-Leclercq MP; Dufrêne YF
    J Bacteriol; 2008 Dec; 190(24):7904-9. PubMed ID: 18835985
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasmid-encoded lysostaphin endopeptidase resistance of Staphylococcus simulans biovar staphylolyticus.
    Heath HE; Heath LS; Nitterauer JD; Rose KE; Sloan GL
    Biochem Biophys Res Commun; 1989 May; 160(3):1106-9. PubMed ID: 2730641
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Internally quenched peptides for the study of lysostaphin: An antimicrobial protease that kills Staphylococcus aureus.
    Warfield R; Bardelang P; Saunders H; Chan WC; Penfold C; James R; Thomas NR
    Org Biomol Chem; 2006 Oct; 4(19):3626-38. PubMed ID: 16990938
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potent, synergistic inhibition of Staphylococcus aureus upon exposure to a combination of the endopeptidase lysostaphin and the cationic peptide ranalexin.
    Graham S; Coote PJ
    J Antimicrob Chemother; 2007 Apr; 59(4):759-62. PubMed ID: 17324959
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Binding and degradation of elastin by the staphylolytic enzyme lysostaphin.
    Park PW; Senior RM; Griffin GL; Broekelmann TJ; Mudd MS; Mecham RP
    Int J Biochem Cell Biol; 1995 Feb; 27(2):139-46. PubMed ID: 7767782
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanism and suppression of lysostaphin resistance in oxacillin-resistant Staphylococcus aureus.
    Climo MW; Ehlert K; Archer GL
    Antimicrob Agents Chemother; 2001 May; 45(5):1431-7. PubMed ID: 11302806
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural and Functional Insights Into Lysostaphin-Substrate Interaction.
    Tossavainen H; Raulinaitis V; Kauppinen L; Pentikäinen U; Maaheimo H; Permi P
    Front Mol Biosci; 2018; 5():60. PubMed ID: 30018958
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Novel Chimeric Endolysin with Antibacterial Activity against Methicillin-Resistant
    Haddad Kashani H; Fahimi H; Dasteh Goli Y; Moniri R
    Front Cell Infect Microbiol; 2017; 7():290. PubMed ID: 28713777
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cell wall monoglycine cross-bridges and methicillin hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureus.
    Strandén AM; Ehlert K; Labischinski H; Berger-Bächi B
    J Bacteriol; 1997 Jan; 179(1):9-16. PubMed ID: 8981974
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modified simplified method for isolation of lysostaphin from the culture filtrate of Staphylococcus staphylolyticus.
    Márová I; Dadák V
    Folia Microbiol (Praha); 1993; 38(3):245-52. PubMed ID: 8365700
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Simple Protocol for the Determination of Lysostaphin Enzymatic Activity.
    Grishin AV; Konstantinova SV; Vasina IV; Shestak NV; Karyagina AS; Lunin VG
    Antibiotics (Basel); 2020 Dec; 9(12):. PubMed ID: 33348544
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of vancomycin and lysostaphin resistance in a methicillin-resistant Staphylococcus aureus isolate.
    Boyle-Vavra S; Carey RB; Daum RS
    J Antimicrob Chemother; 2001 Nov; 48(5):617-25. PubMed ID: 11679550
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cloning, Expression, and Purification of Recombinant Lysostaphin From Staphylococcus simulans.
    Farhangnia L; Ghaznavi-Rad E; Mollaee N; Abtahi H
    Jundishapur J Microbiol; 2014 May; 7(5):e10009. PubMed ID: 25147708
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of lysostaphin in HeLa cells protects from host cell killing by intracellular Staphylococcus aureus.
    Klein M; Krönke M; Krut O
    Med Microbiol Immunol; 2006 Sep; 195(3):159-63. PubMed ID: 16482441
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reducing Staphylococcus aureus resistance to lysostaphin using CRISPR-dCas9.
    Wu X; Zha J; Koffas MAG; Dordick JS
    Biotechnol Bioeng; 2019 Dec; 116(12):3149-3159. PubMed ID: 31433061
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic applications of lysostaphin against Staphylococcus aureus.
    Jayakumar J; Kumar VA; Biswas L; Biswas R
    J Appl Microbiol; 2021 Sep; 131(3):1072-1082. PubMed ID: 33382154
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design of a polypeptide FRET substrate that facilitates study of the antimicrobial protease lysostaphin.
    Bardelang P; Vankemmelbeke M; Zhang Y; Jarvis H; Antoniadou E; Rochette S; Thomas NR; Penfold CN; James R
    Biochem J; 2009 Mar; 418(3):615-24. PubMed ID: 19032148
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-staphylococcal activities of lysostaphin and LytM catalytic domain.
    Sabala I; Jonsson IM; Tarkowski A; Bochtler M
    BMC Microbiol; 2012 Jun; 12():97. PubMed ID: 22672475
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Facile penetration of the Staphylococcus aureus capsule by lysostaphin.
    King BF; Biel ML; Wilkinson BJ
    Infect Immun; 1980 Sep; 29(3):892-6. PubMed ID: 7429637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.